|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3400239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17736478.3 |
| Date of filing the European patent application | 2017-01-06 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/012621 |
| Date | 2017-01-06 |
| (87) | Number | WO 2017/120534 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201662276806 P | 2016-01-08 | US |
| (72) |
LIN, Rong-Hwa , US
LIN, Shih-Yao , TW
TSAI, Yu-Ying , TW
|
| (73) |
AltruBio Inc. ,
1209 Orange Street, Wilmington, New Castle County, DE 19801,
US
|
| (54) | TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |
| TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |